Prilenia Appoints Rick Munschauer Chief Medical Officer Ahead of Phase 3 Trials

Prilenia Therapeutics has appointed veteran neurologist and biopharmaceutical executive Frederick “Rick” E. Munschauer III, MD, MSc, FAAN, as chief medical... Read More

The post Prilenia Appoints Rick Munschauer Chief Medical Officer Ahead of Phase 3 Trials appeared first on citybiz.